Nephrocare Health Services Lists at 7% Premium Over IPO Price

martes, 16 de diciembre de 2025, 11:29 pm ET1 min de lectura

Nephrocare Health Services, India's largest dialysis services provider, listed at a 7% premium over its IPO price on Thursday. The Rs 871.39 crore IPO saw robust demand, with the issue subscribed 14.08 times overall. The company plans to use proceeds from the fresh issue to reduce debt and expand dialysis centers. Financially, Nephrocare has delivered strong growth, with revenue rising 34% and profit after tax jumping 91% in FY25. However, analysts have flagged valuation concerns.

Nephrocare Health Services Lists at 7% Premium Over IPO Price

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios